[{"data":1,"prerenderedAt":135},["ShallowReactive",2],{"naujienos/eu-investment-in-the-future-of-science-allows-for-wider-application-of-genetic-engineering/en":3},{"status":4,"data":5},true,{"image":6,"id":14,"seo":15,"title":12,"date":90,"url":86,"fullUrl":26,"text":91,"excerpt":25,"more":92,"tags":133,"temos":134},{"src":7,"is_svg":8,"ratio":9,"width":10,"height":11,"alt":12,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2022/12/caszyme-mokslininke-1.jpg",false,0.6666666666666666,300,200,"EU Investment in the Future of Science Allows for Wider Application of Genetic Engineering","",6826,{"title":16,"robots":17,"og_locale":23,"og_type":24,"og_title":16,"og_description":25,"og_url":26,"og_site_name":27,"article_publisher":28,"og_image":29,"twitter_card":34,"schema":35,"breadcrumbs":78,"description":13,"language":87},"EU Investment in the Future of Science Allows for Wider Application of Genetic Engineering - Inovacijų agentūra",{"index":18,"follow":19,"max-snippet":20,"max-image-preview":21,"max-video-preview":22},"index","follow","max-snippet:-1","max-image-preview:large","max-video-preview:-1","en_US","article","EU investment has accelerated Caszyme company’s research progress, expanded the Cas protein database and made the company more competitive on the market. The solutions offered by the Lithuanian start-up help businesses choose the optimal use of gene editing technology. “Genetic scissors” have already been applied in many research fields, including medicine, for the treatment of genetic and oncological diseases, and agriculture, for the development of plant varieties that are resistant to diseases, pests and the effects of climate change.","https://www.inovacijuagentura.lt/en/naujiena/eu-investment-in-the-future-of-science-allows-for-wider-application-of-genetic-engineering/","Inovacijų agentūra","https://www.facebook.com/inovacijuagentura",[30],{"width":31,"height":32,"url":7,"type":33},"300","200","image/jpeg","summary_large_image",{"@context":36,"@graph":37},"https://schema.org",[38,53,55,65,69],{"@type":39,"@id":26,"url":26,"name":16,"isPartOf":40,"primaryImageOfPage":42,"image":44,"thumbnailUrl":7,"datePublished":45,"breadcrumb":46,"inLanguage":48,"potentialAction":49},"WebPage",{"@id":41},"https://www.inovacijuagentura.lt/en/#website",{"@id":43},"https://www.inovacijuagentura.lt/en/naujiena/eu-investment-in-the-future-of-science-allows-for-wider-application-of-genetic-engineering/#primaryimage",{"@id":43},"2022-12-27T08:00:00+00:00",{"@id":47},"https://www.inovacijuagentura.lt/en/naujiena/eu-investment-in-the-future-of-science-allows-for-wider-application-of-genetic-engineering/#breadcrumb","en-US",[50],{"@type":51,"target":52},"ReadAction",[26],{"@type":54,"inLanguage":48,"@id":43,"url":7,"contentUrl":7,"width":31,"height":32,"caption":12},"ImageObject",{"@type":56,"@id":47,"itemListElement":57},"BreadcrumbList",[58,63],{"@type":59,"position":60,"name":61,"item":62},"ListItem","1","Home","https://www.inovacijuagentura.lt/en/",{"@type":59,"position":64,"name":12},"2",{"@type":66,"@id":41,"url":62,"name":27,"description":13,"publisher":67,"inLanguage":48},"WebSite",{"@id":68},"https://www.inovacijuagentura.lt/en/#organization",{"@type":70,"@id":68,"name":27,"url":62,"logo":71,"image":76,"sameAs":77},"Organization",{"@type":54,"inLanguage":48,"@id":72,"url":73,"contentUrl":73,"width":74,"height":75,"caption":27},"https://www.inovacijuagentura.lt/en/#/schema/logo/image/","https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/ia-logo-main.svg","1886","786",{"@id":72},[28],[79,82,85],{"url":80,"text":61,"id":81},"/en/",7576,{"url":83,"text":84},"/en/news/","News",{"url":86,"text":12,"id":14},"/en/naujiena/eu-investment-in-the-future-of-science-allows-for-wider-application-of-genetic-engineering/",[88],{"url":26,"code":89,"locale":89,"default":8},"en","2022-12-27","\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">“We are developing genome editing tools, the “genetic scissors”, based on CRISPR-Cas systems. This is a targeted approach to DNA sequence modification that has revolutionised the entire field of genetic engineering. Previously long, expensive and complex processes have become cheaper, faster and more accurate thanks to the development of new tools. We help companies apply gene editing solutions to their operations to reduce the costs and risks of research and experimental development (R&D) and increase the likelihood of their business success,’ explained Karolina Makovskytė, Business Development Manager at Caszyme.\u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">The Technology Is Widely Applicable \u003C/span>\u003C/span>\u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">“CRISPR-Cas genome editing technology has already been effectively applied in the pharmaceutical and chemical industries, in the production of molecular reagents and in the development of biotechnology science. In medicine, several clinical trials are currently underway to develop therapies for genetic and oncological diseases,” said Ms Makovskytė. \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">The application of \u003Cem>Cas\u003C/em> proteins is constantly expanding. In the context of climate change, for example, this technology has become particularly\u003Cem> \u003C/em>relevant in agriculture\u003Cem>.\u003C/em> \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">“It is being used to increase the resistance of plants to various diseases and pests. It is also being used to develop plant varieties that are more resistant to rapidly changing climatic conditions. This helps produce higher yields and crops with higher nutritional value,” noted Ms Makovskytė. \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">In the future, she says, the development of new molecular tools and the improvement of existing ones will not only open up new opportunities to accelerate research in a wide range of fields, but will also provide the basis for a new scientific breakthrough. \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">The Investment Accelerated the Project's Implementation \u003C/span>\u003C/span>\u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">“After submitting the project application, we received funding to carry out research and add \u003Cem>Cas\u003C/em> proteins with new properties to our database. This allowed us to accelerate the expansion of our existing database and increase our competitiveness on the market,” said Ms Makovskytė.  \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">The search for and development of tools for CRISPR-Cas genome editing technology is a very important part of Caszyme's activities. \u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">“With the completion of the project activities in October, we have been continuing to actively commercialise the solutions developed during the project and we do not intend to stop. To meet the market needs and global trends in technology development, we plan to continue expanding our company's services and expanding the database of molecular genome editing tools,” said Ms Makovskytė.\u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">For the implementation of the project under the EU measure \u003Cem>Experimentas\u003C/em>, the Innovation Agency (formerly, Lithuanian Business Support Agency) granted UAB Caszyme \u003C/span>\u003C/span>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">€\u003C/span>\u003C/span>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">200,000 in funding. The total budget of the project was close to \u003C/span>\u003C/span>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">€\u003C/span>\u003C/span>\u003Cspan style=\"background-color:white\">\u003Cspan style=\"color:black\">300,000. One third of this amount was invested by the company itself.\u003C/span>\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>\u003Cspan style=\"color:black\">Consistent Investment in Innovation \u003C/span>\u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"color:black\">Over \u003C/span>\u003Cspan style=\"color:black\">€\u003C/span>\u003Cspan style=\"color:black\">310 million have already been invested in business research and experimental development in the 2014-2020 funding period, with 251 projects completed and 236 ongoing. The programme will result in a total of 864 innovative product prototypes.\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"color:black\">“\u003C/span>\u003Cspan style=\"color:#282338\">To further stimulate the supply of innovation, we launched the \u003Cem>InoStartas \u003C/em>call last week. Its main activities will enable researchers to participate in R&D projects in companies, launch pilot production of newly developed products and prepare them for the market. We are also planning to launch two more calls early next year: \u003Cem>InoPažanga\u003C/em> and \u003Cem>InoBranda\u003C/em> for the deployment of R&D innovations,” said Agnė Vaitkūnienė, Director of the Investment Management Department of the Innovation Agency.\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cem>\u003Cspan style=\"color:black\">InoStart\u003C/span>\u003C/em>\u003Cspan style=\"color:black\">as, \u003Cem>InoPažanga\u003C/em> and \u003Cem>InoBranda\u003C/em> are part of the 2022-2030 Economic Transformation and Competitiveness Development Programme managed by the Ministry of the Economy and Innovation of the Republic of Lithuania. The project activities are financed by the EU investment funds.\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cspan style=\"color:black\">All calls are published on the \u003C/span>\u003Ca href=\"https://kc.inovacijuagentura.lt/kcis/finansines-priemones/finansavimo-priemones?lang=lt\">\u003Cspan style=\"color:#0563c1\">website\u003C/span>\u003C/a>\u003Cu> \u003C/u>\u003Cspan style=\"color:black\">of Innovation Agency's funding instruments.\u003C/span>\u003C/p>\n\u003Cp style=\"text-align:justify\"> \u003C/p>\n",[93,102,111,125],{"image":94,"title":97,"url":98,"id":99,"text":100,"temos":101},{"src":95,"is_svg":8,"ratio":96,"alt":97,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/kosmoso-memorandumas-su-polsa.jpg",0.6669921875,"Lithuania Strengthens Cooperation with Poland and the United States in the Space Sector: Important Memorandums Signed","/en/naujiena/lithuania-strengthens-cooperation-with-poland-and-the-united-states-in-the-space-sector-important-memorandums-signed/",6748,"Lithuania’s space sector continues to strengthen international partnerships and expand cooperation with key players in the global space industry. Innovation Agency Lithuania has recently signed two significant memorandums of understanding – with the Polish Space Agency (POLSA) and the U.S. space infrastructure company Vast. These agreements open new opportunities for Lithuanian businesses, research institutions, and international projects.",[],{"image":103,"title":106,"url":107,"id":108,"text":109,"temos":110},{"src":104,"is_svg":8,"ratio":105,"alt":106,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/03/shutterstock-2539768243-1.jpg",0.7490234375,"Lithuania Ranks First in Europe in the Global Entrepreneurship Index","/en/naujiena/lithuania-ranks-first-in-europe-in-the-global-entrepreneurship-index/",6892,"The latest Global Entrepreneurship Monitor (GEM) 2025/2026 global report shows that Lithuania is the leading country in Europe in terms of the quality of its entrepreneurial environment and ranks among the world’s strongest economies in this field.",[],{"image":112,"title":114,"url":115,"id":116,"text":117,"temos":118},{"src":113,"is_svg":8,"ratio":96,"alt":114,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/01/karolina-urbonaite.jpg","Lithuania’s Startup Ecosystem Surpasses €16.4 Billion in Value: Investments Jump 1.7x in 2025","/en/naujiena/lithuanias-startup-ecosystem-surpasses-e16-4-billion-in-value-investments-jump-1-7x-in-2025/",6999,"The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just one year, Lithuanian startups attracted €220 million in venture capital investments from 77 unique investors. The ecosystem’s growing maturity was further confirmed earlier this year with the addition of a new unicorn to Lithuania’s startup map — Cast AI.",[119,122],{"id":120,"name":121},577,"Growth",{"id":123,"name":124},579,"Innovation",{"image":126,"title":128,"url":129,"id":130,"text":131,"temos":132},{"src":127,"is_svg":8,"ratio":96,"alt":128,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/12/modix-fgf-3d-spausdintuvas-2.jpg","Mission-Driven Innovations: Science and Business Shaping Lithuania’s Future","/en/naujiena/mission-driven-innovations-science-and-business-shaping-lithuanias-future/",6904,"Some important scientific research activities and innovative business-developed products may sound complex – unsurprisingly, as they are developed by people who dedicate their entire lives to these fields. Yet behind these sophisticated terms lie concrete solutions that will eventually make each of our daily lives easier. Where science and business join forces, more accurate disease diagnostics for the health of us and our loved ones are developed, cybersecurity tools are created to protect the country, and climate-neutral production technologies and materials emerge to help preserve our nature and resources.",[],[],[],1780325204740]